US Senator Charles Grassley is awaiting a response from orthopaedic implant specialist Zimmer after he raised concerns over the firm’s quality systems procedures. The senator sent a letter to the company dated 29 July, asking that it to provide the US Senate Finance Committee ...
Please Login to read the full article.
